Sickle Cell Disease: Clinical Trials

4 trials for Sickle Cell Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Terminated 4

Follow Sickle Cell Disease: new trials by email Literature Review of Sickle Cell Disease trials Research Report on Sickle Cell Disease

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
Deferiprone - Iron Overload, Sickle Cell Disease
Phase 4TerminatedApoPharma1342015-05-212024-01-10
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Deferiprone, Deferoxamine - Iron Overload, Sickle Cell Disease
Phase 4TerminatedApoPharma2302014-04-172021-08-10
Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease - Sickle With Ibuprofen & Morphine
Ibuprofen, Placebo, Diamorphine or Morphine - Sickle Cell Disease
Phase 4TerminatedLondon North West Healthcare NHS Trust3202011-03-012012-12-04
Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
Ketamine - Sickle Cell Disease
Phase 4TerminatedChildren's Hospital of Philadelphia32004-06-012009-03-13

Narrower conditions

Anemia, Sickle Cell (4)  ·  Iron Overload (2)  ·  Pain (1)

Broader conditions

Anemia (4)  ·  Anemia, Hemolytic (4)  ·  Anemia, Hemolytic, Congenital (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Hemoglobinopathies (4)  ·  Iron Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Deferiprone (2)  ·  Deferoxamine (1)  ·  Heroin (1)  ·  Ibuprofen (1)  ·  Ketamine (1)  ·  Morphine (1)

Sponsors

ApoPharma (2)  ·  Children's Hospital of Philadelphia (1)  ·  London North West Healthcare NHS Trust (1)

Countries

United Kingdom (3)  ·  United States (3)  ·  Canada (2)  ·  Egypt (2)  ·  Saudi Arabia (2)  ·  Brazil (1)  ·  Tunisia (1)  ·  Turkey (Türkiye) (1)

Top investigators

Janet Kwiatkowski, MD (2)  ·  Arjunan Ganesh, MD (1)  ·  Caroline Dore, BSc (1)  ·  Gavin Cho, MD (1)  ·  Kofi A Anie, PhD (1)  ·  Mark Layton, MD (1)  ·  Sarah Meredith, MD (1)

Results publications

PMID 27288381, PMID 34847228, PMID 36018224, PMID 37807937